본문 바로가기

Fibroblast Growth Factor 11 Inhibits Hepatitis B Virus Gene Expression Through FXRa Suppression

Fibroblast Growth Factor 11 Inhibits Hepatitis B Virus Gene Expression Through FXRα Suppression

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q2KCI Q3
저널
JOURNAL OF MICROBIOLOGY61(7) · pp.693 · 2023
피인용
Web of Science 2Scopus 2KCI 0
FWCI (Scopus)
0.19
JCR IF
JCR 2022 3
ISSN
1225-8873

저자

  1. 성미소제1저자Pusan Natl Univ, Dept Mol Biol, Busan 46241, South Korea
  2. 장정아Pusan Natl Univ, Dept Mol Biol, Busan 46241, South Korea
  3. 정예림Pusan Natl Univ, Dept Mol Biol, Busan 46241, South Korea
  4. 김예빈Pusan Natl Univ, Dept Mol Biol, Busan 46241, South Korea
  5. Kyaw, Yi YiRepubl Union Myanmar, Dept Med Res, Adv Mol Res Ctr, Yangon 11191, Myanmar
  6. Kong, Hee JeongNatl Inst Fisheries Sci, Biotechnol Res Div, Busan 46083, South Korea
  7. Lee, Jung-HyunKorea Inst Ocean Sci & Technol, Marine Biotechnol Res Ctr, Busan 49111, South Korea
  8. 정재훈교신저자Pusan Natl Univ, Dept Mol Biol, Busan 46241, South Korea

초록

Fibroblast growth factor 11 (FGF11) is a member of the intracellular FGF family, which shows different signal transmission compared with other FGF superfamily members. The molecular function of FGF11 is not clearly understood. In this study, we identified the inhibitory effect of FGF11 on hepatitis B virus (HBV) gene expression through transcriptional suppression. FGF11 decreased the mRNA and protein expression of HBV genes in liver cells. While the nuclear receptor FXRα1 increased HBV promoter transactivation, FGF11 decreased the FXRα-mediated gene induction of the HBV promoter by the FXRα agonist. Reduced endogenous levels of FXRα by siRNA and the dominant negative mutant protein (aa 1–187 without ligand binding domain) of FXRα expression indicated that HBV gene suppression by FGF11 is dependent on FXRα inhibition. In addition, FGF11 interacts with FXRα protein and reduces FXRα protein stability. These results indicate that FGF11 inhibits HBV replicative expression through the liver cell-specific transcription factor, FXRα, and suppresses HBV promoter activity. Our findings may contribute to the establishment of better regimens for the treatment of chronic HBV infections by including FGF11 to alter the bile acid mediated FXR pathway.

키워드

Antiviral effectFGF11FXRHBx proteinHepatitis B virusFARNESOID-X-RECEPTORHEPATOCELLULAR-CARCINOMACORE PROMOTERLIVERENHANCERHYPOXIAROLESMETABOLISMELEMENTSTHERAPY

식별자

Scopus EID
2-s2.0-85169168062
WoS UID
001189072000001
KCI
ART002993769